Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2281 to 2295 of 7683 results

  1. School-based interventions: physical and mental health and wellbeing promotion

    In development [GID-QS10070] Expected publication date: TBC

    Quality standard
    In development

  2. NVK-002 for treating myopia in people 3 to 17 years TSID 11961

      Status ...

    Technology appraisal guidance
    Topic selection

  3. Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis TS ID 12050

      Status ...

    Technology appraisal guidance
    Topic selection

  4. Sotatercept for treating pulmonary arterial hypertension [ID6163]

    In development [GID-TA11103] Expected publication date: 15 October 2025

    Technology appraisal guidance
    In development

  5. Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and living with overweight or obesity ID6441

    In development [GID-TA11544] Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Budesonide oral suspension for maintaining remission of eosinophilic oesophagitis in people 2 years and over TS ID 12082

      Status ...

    Technology appraisal guidance
    Topic selection

  7. Relugolix–estradiol–norethisterone for treating symptoms of endometriosis [ID3982]

    In development [GID-TA10873] Expected publication date: TBC

    Technology appraisal guidance
    In development

  8. Pembrolizumab with chemoradiation, then with or without olaparib, for untreated unresectable locally advanced non-small-cell lung cancer ID6399

    Awaiting development [GID-TA11499] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  10. Tiragolumab with atezolizumab for treating advanced oesophageal squamous cell cancer after chemoradiotherapy [ID6267]

    Awaiting development [GID-TA11299] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Artificial intelligence software to help detect and characterise colorectal polyps

    In development [GID-DG10118] Expected publication date: TBC

    Diagnostics guidance
    In development

  12. Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]

    In development [GID-TA11373] Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Pembrolizumab for neoadjuvant and with radiotherapy for adjuvant treatment of newly diagnosed resectable locally advanced squamous cell head and neck cancer TS ID 12068

    Awaiting development [GID-TA11599] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Vamorolone for treating Duchenne muscular dystrophy [ID4024]

    In development [GID-TA11135] Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids

    Register an interest in this interventional procedure The National Institute for Health and Clinical Excellence (NICE) issued full guid...

    Interventional procedures guidance
    Topic selection